High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

Ingeborg Fraunholz,Claus Rödel,Luitpold Distel,Margret Rave-Fränk,Daniela Kohler,Stefan Falk,Franz Rödel

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

2012

Ingeborg Fraunholz
Claus Rödel
Luitpold Distel
Margret Rave-Fränk
Daniela Kohler
Stefan Falk
Franz Rödel

Purpose To investigate the prognostic value of survivin expression in pretreatment specimens from patients with anal cancer treated with concurrent 5-FU and mitomycin C-based chemoradiation (CRT).

Keywords:

Fluorouracil
Survivin
Anal cancer
Risk factor
Chemoradiotherapy
Anal Carcinoma
Radiation therapy
Internal medicine
Immunohistochemistry
Medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations